Literature DB >> 2515628

Seroprevalence of Trypanosoma cruzi infection among unskilled urban workers in central Brazil.

F Zicker1, R M Oliveira, A O Luquetti, O S Oliveira, P G Smith.   

Abstract

A cross-sectional survey of the prevalence of Trypanosoma cruzi infection was carried out among urban unskilled workers in an endemic area in central Brazil as part of a study to assess the health impact of Chagas disease and to identify risk factors for the evolution of cardiopathy. Blood samples from 5425 male and female workers, aged 15-61 years, from 5 public institutions, were screened by indirect immunofluorescence, enzyme-linked immunosorbent assay and indirect haemagglutination for antibodies to T. cruzi. Seroprevalence varied from 8.8% to 15.6% in the different institutions and increase with age up to 55 years. More stable jobs were associated with lower seroprevalence. Migrants from São Paulo and Minas Gerais presented higher prevalence and a relative risk associated with seropositivity in relation to workers from Goiás of 2.2 (95% confidence limits, 1.4-3.5) and 1.9 (1.6-2.3), respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515628     DOI: 10.1016/0035-9203(89)90269-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Parasitic diseases and urban development.

Authors:  K E Mott; P Desjeux; A Moncayo; P Ranque; P de Raadt
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Spatial patterns of leprosy in an urban area of central Brazil.

Authors:  C M Martelli; O L Moraes Neto; A L Andrade; S A Silva; I M Silva; F Zicker
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

3.  Surveillance of Trypanosoma cruzi transmission by serological screening of schoolchildren.

Authors:  A L de Andrade; F Zicker; A O Luquetti; R M Oliveira; S A Silva; J M Souza; C M Martelli
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.